Opening CONDITION POWER IN INTERIM ANALYSES OF A CLINICAL TRIAL _ DR. L. JEYASEELAN
CONDITION POWER IN INTERIM ANALYSES OF A CLINICAL TRIAL _ DR. L. JEYASEELAN
- Length
- 36 min
- Level
- Undergraduate
- Recorded
- Christian Medical College Vellore2024
Chapter 1 of 5: Interim analysis rules and stopping questions
Conditional power in a clinical trial gives the probability of reaching a statistically significant result, given the data observed at an interim analysis. Jeyaseelan starts from scheduled interim looks and the stopping questions put to data safety monitoring boards. He then defines conditional power under the design assumption, under the current observed trend, and under the null hypothesis of no further difference. The PLACID trial of convalescent plasma, published in the BMJ, serves as the worked case, with calculations run in a Shiny app. A current-trend conditional power below thirty percent supports stopping for futility; the session assumes P values, standard errors and sample size.

Your comment is kept while you sign up.Sign in
Recomputes conditional power at interim looks of the ICMR convalescent plasma trial for COVID-19 to test early stopping.
Conditional power in a clinical trial gives the probability of reaching a statistically significant result, given the data observed at an interim analysis. Jeyaseelan starts from scheduled interim looks and the stopping questions put to data safety monitoring boards. He then defines conditional power under the design assumption, under the current observed trend, and under the null hypothesis of no further difference. The PLACID trial of convalescent plasma, published in the BMJ, serves as the worked case, with calculations run in a Shiny app. A current-trend conditional power below thirty percent supports stopping for futility; the session assumes P values, standard errors and sample size.
Convalescent plasma in the management of moderate COVID-19 in adults in India: Open label phase III multicentre randomised controlled trial (PLACID Trial)
BMJ Paper on Convalescent Plasma Therapy
This lecture
Lecture 12 of 14 of Clinical Trials Course - 2023.
Choose a node to see how it connects to this lecture. What comes before is on the leftat the top. What comes after is on the rightat the bottom. The ring is what it teaches. People and places are above. Other lectures and books are below.
Press a chosen node again to open it.